On the public citation graph

The Role of Target Binding Kinetics in Drug Discovery

0 signed · 94 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/bdd.1871openalex-snapshot
Systems pharmacology modeling: an approach to improving drug safety
inferredcites →https://doi.org/10.1002/cmdc.201300474openalex-snapshot
Binding Kinetics of ZM241385 Derivatives at the Human Adenosine A2A Receptor
inferredcites →https://doi.org/10.1002/med.21307openalex-snapshot
Drug‐Target Residence Time—A Case for G Protein‐Coupled Receptors
inferredcites →https://doi.org/10.1002/prot.22767openalex-snapshot
New hypotheses about the structure–function of proprotein convertase subtilisin/kexin type 9: Analysis of the epidermal growth factor‐like repeat A docking site using WaterMap
inferredcites →https://doi.org/10.1007/s00210-012-0734-2openalex-snapshot
Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism
inferredcites →https://doi.org/10.1016/j.bcp.2006.07.011openalex-snapshot
Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure–activity relationships and insurmountable antagonism
inferredcites →https://doi.org/10.1016/j.bmc.2011.02.033openalex-snapshot
Molecular properties affecting fast dissociation from the D2 receptor
inferredcites →https://doi.org/10.1016/j.bmcl.2014.08.026openalex-snapshot
Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of pyrrolopiperidinone acetic acids as CRTh2 antagonists
inferredcites →https://doi.org/10.1016/j.bmcl.2014.08.028openalex-snapshot
Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists III: The role of a hydrogen-bond acceptor in long receptor residence times
inferredcites →https://doi.org/10.1016/j.bmcl.2014.09.005openalex-snapshot
Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists I
inferredcites →https://doi.org/10.1016/j.bmcl.2014.12.076openalex-snapshot
Target Engagement in Lead Generation
inferredcites →https://doi.org/10.1016/j.drudis.2008.11.011openalex-snapshot
G-protein-coupled receptor-focused drug discovery using a target class platform approach
inferredcites →https://doi.org/10.1016/j.drudis.2011.06.013openalex-snapshot
Target–drug interactions: first principles and their application to drug discovery
inferredcites →https://doi.org/10.1016/j.drudis.2013.02.007openalex-snapshot
Molecular determinants of drug–receptor binding kinetics
inferredcites →https://doi.org/10.1016/j.drudis.2013.02.010openalex-snapshot
Pharmacokinetics and the drug–target residence time concept
inferredcites →https://doi.org/10.1016/j.ejmech.2015.01.063openalex-snapshot
When structure–affinity relationships meet structure–kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists
inferredcites →https://doi.org/10.1016/j.ejphar.2012.07.007openalex-snapshot
Functional and binding kinetic studies make a distinction between OX1 and OX2 orexin receptor antagonists
inferredcites →https://doi.org/10.1016/s0006-3223(00)00635-1openalex-snapshot
371. Transient d2 dopamine receptor occupancy in low EPS-incidence drugs: PET evidence
inferredcites →https://doi.org/10.1016/s0006-3223(99)00111-0openalex-snapshot
Eye deviation during rotation in darkness in trait anxiety: an early expression of perceptual avoidance?
inferredcites →https://doi.org/10.1021/bi8002023openalex-snapshot
Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function
inferredcites →https://doi.org/10.1021/jm4011737openalex-snapshot
Structure–Kinetic Relationships—An Overlooked Parameter in Hit-to-Lead Optimization: A Case of Cyclopentylamines as Chemokine Receptor 2 Antagonists
inferredcites →https://doi.org/10.1021/jm401219yopenalex-snapshot
Molecular Basis for the Long Duration of Action and Kinetic Selectivity of Tiotropium for the Muscarinic M3 Receptor
inferredcites →https://doi.org/10.1021/jm401643mopenalex-snapshot
Agonists for the Adenosine A1Receptor with Tunable Residence Time. A Case for Nonribose 4-Amino-6-aryl-5-cyano-2-thiopyrimidines
inferredcites →https://doi.org/10.1021/jm900948qopenalex-snapshot
Identification of a Critical Residue in the Transmembrane Domain 2 of Tachykinin Neurokinin 3 Receptor Affecting the Dissociation Kinetics and Antagonism Mode of Osanetant (SR 142801) and Piperidine-Based Structures
inferredcites →https://doi.org/10.1038/nature10867openalex-snapshot
Structure and dynamics of the M3 muscarinic acetylcholine receptor
inferredcites →https://doi.org/10.1038/nchembio.206openalex-snapshot
Sustained cyclic AMP production by parathyroid hormone receptor endocytosis
inferredcites →https://doi.org/10.1038/nrd3954openalex-snapshot
Signalling bias in new drug discovery: detection, quantification and therapeutic impact
inferredcites →https://doi.org/10.1038/sj.bjp.0706819openalex-snapshot
Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M 3 receptor
inferredcites →https://doi.org/10.1039/c2md00270aopenalex-snapshot
Investigation of the effect of molecular properties on the binding kinetics of a ligand to its biological target
inferredcites →https://doi.org/10.1073/pnas.1104614108openalex-snapshot
Pathway and mechanism of drug binding to G-protein-coupled receptors
inferredcites →https://doi.org/10.1111/bph.12245openalex-snapshot
Binding kinetics differentiates functional antagonism of orexin‐2 receptor ligands
inferredcites →https://doi.org/10.1111/j.1476-5381.2010.00936.xopenalex-snapshot
Long‐lasting target binding and rebinding as mechanisms to prolongin vivodrug action
inferredcites →https://doi.org/10.1124/jpet.107.124958openalex-snapshot
Neurokinin 1 Receptor Antagonists: Correlation between in Vitro Receptor Interaction and in Vivo Efficacy
inferredcites →https://doi.org/10.1124/jpet.111.188714openalex-snapshot
Binding Kinetics Redefine the Antagonist Pharmacology of the Corticotropin-Releasing Factor Type 1 Receptor
inferredcites →https://doi.org/10.1124/jpet.112.194456openalex-snapshot
The Influence of Receptor Kinetics on the Onset and Duration of Action and the Therapeutic Index of NVA237 and Tiotropium
inferredcites →https://doi.org/10.1124/mol.107.035535openalex-snapshot
Trapping of a Nonpeptide Ligand by the Extracellular Domains of the Gonadotropin-Releasing Hormone Receptor Results in Insurmountable Antagonism
inferredcites →https://doi.org/10.1146/annurev-pharmtox-010611-134520openalex-snapshot
Systems Pharmacology: Network Analysis to Identify Multiscale Mechanisms of Drug Action
inferredcites →https://doi.org/10.1146/annurev.pharmtox.48.113006.094830openalex-snapshot
Regulation of GPCRs by Endocytic Membrane Trafficking and Its Potential Implications
inferredcites →https://doi.org/10.1177/0269881111435251openalex-snapshot
In vivo quantification of striatal dopamine D 2 receptor occupancy by JNJ-37822681 using [ 11 C]raclopride and positron emission tomography
inferredcites →https://doi.org/10.1210/me.2012-1404openalex-snapshot
Minireview: Ubiquitination-regulated G Protein-Coupled Receptor Signaling and Trafficking
inferredcites →https://doi.org/10.1517/17460441.1.5.439openalex-snapshot
Label-free kinetic binding data as a decisive element in drug discovery
inferredcites →https://doi.org/10.1517/17460441.2010.512037openalex-snapshot
Rebinding: or why drugs may act longerin vivothan expected from theirin vitrotarget residence time
inferredcites →https://doi.org/10.1517/17460441.2010.520700openalex-snapshot
Binding kinetics and mechanism of action: toward the discovery and development of better and best in class drugs
inferredcites →https://doi.org/10.2174/156802606776743093openalex-snapshot
Biochemical Mechanisms of New Molecular Entities (NMEs) Approved by United States FDA During 2001-2004: Mechanisms Leading to Optimal Efficacy and Safety

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/chem.201700417openalex-snapshot
Template‐Mediated Stabilization of a DNA G‐Quadruplex formed in the HIV‐1 Promoter and Comparative Binding Studies
inferred← citeshttps://doi.org/10.1002/cmdc.202501029openalex-snapshot
An Internal Sulfur–Lone Pair Interaction Enabled the Discovery of Potent and Sub‐Family Selective PKMYT1 Inhibitors
inferred← citeshttps://doi.org/10.1002/cplu.202100134openalex-snapshot
On‐Cell NMR Contributions to Membrane Receptor Binding Characterization
inferred← citeshttps://doi.org/10.1002/pro.4398openalex-snapshot
Characterizing (un)binding mechanism of USP7 inhibitors to unravel the cause of enhanced binding potencies at allosteric checkpoint
inferred← citeshttps://doi.org/10.1007/7355_2021_120openalex-snapshot
Kinetic Profiling of Ligands and Fragments Binding to GPCRs by TR-FRET
inferred← citeshttps://doi.org/10.1007/978-1-4939-7465-8_9openalex-snapshot
Molecular Basis of Ligand Dissociation from G Protein-Coupled Receptors and Predicting Residence Time
inferred← citeshttps://doi.org/10.1007/s10858-017-0150-5openalex-snapshot
Label-free NMR-based dissociation kinetics determination
inferred← citeshttps://doi.org/10.1016/j.bcp.2016.02.018openalex-snapshot
Equilibrium and kinetic selectivity profiling on the human adenosine receptors
inferred← citeshttps://doi.org/10.1016/j.bcp.2019.03.032openalex-snapshot
Long residence time adenosine A1 receptor agonists produce sustained wash-resistant antilipolytic effect in rat adipocytes
inferred← citeshttps://doi.org/10.1016/j.bcp.2026.117864openalex-snapshot
Exploring the binding kinetics of intracellular allosteric antagonists for CC chemokine receptor 2 — a key to improve insurmountable antagonism
inferred← citeshttps://doi.org/10.1016/j.bmcl.2017.03.084openalex-snapshot
Pharmacological property optimization for allosteric ligands: A medicinal chemistry perspective
inferred← citeshttps://doi.org/10.1016/j.bpc.2017.06.004openalex-snapshot
Competitive ligands facilitate dissociation of the complex of bifunctional inhibitor and protein kinase
inferred← citeshttps://doi.org/10.1016/j.bpj.2017.05.036openalex-snapshot
The Energetics of Chromophore Binding in the Visual Photoreceptor Rhodopsin
inferred← citeshttps://doi.org/10.1016/j.bpj.2024.12.018openalex-snapshot
Ligand binding kinetics to evaluate the function and stability of A2AR in nanodiscs
inferred← citeshttps://doi.org/10.1016/j.coph.2016.07.004openalex-snapshot
Impact, determination and prediction of drug–receptor residence times for GPCRs
inferred← citeshttps://doi.org/10.1016/j.ctmp.2025.200233openalex-snapshot
Unlocking the therapeutic potential of Balakata baccata flowers: chemical profiling, biological activities, and computational insights of its methanolic extracts
inferred← citeshttps://doi.org/10.1016/j.drudis.2022.103441openalex-snapshot
Allosteric binding cooperativity in a kinetic context
inferred← citeshttps://doi.org/10.1016/j.slasd.2024.100170openalex-snapshot
High-throughput kinetics in drug discovery
inferred← citeshttps://doi.org/10.1016/j.tins.2016.09.008openalex-snapshot
Kinetic Profile of Neuropeptide–Receptor Interactions
inferred← citeshttps://doi.org/10.1021/acs.chemrev.6b00025openalex-snapshot
Kinetic Aspects of the Interaction between Ligand and G Protein-Coupled Receptor: The Case of the Adenosine Receptors
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b00358openalex-snapshot
Uncoupling the Structure–Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b01110openalex-snapshot
Measurement of Ligand–Target Residence Times by 1H Relaxation Dispersion NMR Spectroscopy
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.7b00669openalex-snapshot
Discovery and Kinetic Profiling of 7-Aryl-1,2,4-triazolo[4,3- a ]pyridines: Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.7b00861openalex-snapshot
Structure–Affinity Relationships and Structure–Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.7b01751openalex-snapshot
4-Amino-7,8-dihydro-1,6-naphthyridin-5(6H)-ones as Inhaled Phosphodiesterase Type 4 (PDE4) Inhibitors: Structural Biology and Structure–Activity Relationships
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b00864openalex-snapshot
Structure–Kinetic Profiling of Haloperidol Analogues at the Human Dopamine D2 Receptor
inferred← citeshttps://doi.org/10.1021/acschembio.6b00979openalex-snapshot
Elucidating the Origin of Long Residence Time Binding for Inhibitors of the Metalloprotease Thermolysin
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.6b00273openalex-snapshot
The Added Value of Assessing Ligand–Receptor Binding Kinetics in Drug Discovery
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.8b00590openalex-snapshot
Enhancing Drug Residence Time by Shielding of Intra-Protein Hydrogen Bonds: A Case Study on CCR2 Antagonists
inferred← citeshttps://doi.org/10.1021/acsptsci.0c00012openalex-snapshot
Perspective: Implications of Ligand–Receptor Binding Kinetics for Therapeutic Targeting of G Protein-Coupled Receptors
inferred← citeshttps://doi.org/10.1038/s41598-017-00104-zopenalex-snapshot
A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy
inferred← citeshttps://doi.org/10.1038/srep29895openalex-snapshot
Engineering Factor Xa Inhibitor with Multiple Platelet-Binding Sites Facilitates its Platelet Targeting
inferred← citeshttps://doi.org/10.1039/d3cc03285jopenalex-snapshot
Computational and biophysical methods for the discovery and optimization of covalent drugs
inferred← citeshttps://doi.org/10.1089/nat.2016.0645openalex-snapshot
In Vitro Evaluation of Aptamer-Based Reversible Inhibition of Anticoagulant Activated Protein C as a Novel Supportive Hemostatic Approach
inferred← citeshttps://doi.org/10.1101/2023.11.15.567150openalex-snapshot
Molecular determinants of antagonist interactions with chemokine receptors CCR2 and CCR5
inferred← citeshttps://doi.org/10.1111/febs.16404openalex-snapshot
A guide to enzyme kinetics in early drug discovery
inferred← citeshttps://doi.org/10.1128/aac.00398-20openalex-snapshot
Structural Basis and Binding Kinetics of Vaborbactam in Class A β-Lactamase Inhibition
inferred← citeshttps://doi.org/10.1134/s199075082003004xopenalex-snapshot
Ligand–Receptor Binding Kinetics in Drug Design
inferred← citeshttps://doi.org/10.1177/24725552211000676openalex-snapshot
A Novel High-Throughput FLIPR Tetra–Based Method for Capturing Highly Confluent Kinetic Data for Structure–Kinetic Relationship Guided Early Drug Discovery
inferred← citeshttps://doi.org/10.18097/pbmc20206601042openalex-snapshot
Ligand-receptor binding kinetics in drug design
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2801152/v1openalex-snapshot
Unveiling the molecular recognition process between USP7 N-terminal TRAF-like domain and β-catenin for small molecule discovery
inferred← citeshttps://doi.org/10.26434/chemrxiv.11494170openalex-snapshot
(2-Hydroxy-4-methoxy)benzyl Aminoadamantane Conjugates as Probes to Investigate Specificity Determinants in Blocking Influenza M2 S31N and M2 WT Channels with Binding Kinetics and Simulations
inferred← citeshttps://doi.org/10.3390/cells11081317openalex-snapshot
A Scintillation Proximity Assay for Real-Time Kinetic Analysis of Chemokine–Chemokine Receptor Interactions
inferred← citeshttps://doi.org/10.47758/ijn.v4i0.77openalex-snapshot
Metal Nanoparticles as Novel Drug Delivery Systems: A Review of Current Challenges and Opportunities
inferred← citeshttps://doi.org/10.64898/2026.05.20.726507openalex-snapshot
Protein-ligand binding kinetics are primarily controlled by the protein, not the ligand
inferred← citeshttps://doi.org/10.7554/elife.96513openalex-snapshot
Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD)
inferred← citeshttps://doi.org/10.7554/elife.96513.1openalex-snapshot
Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD)
inferred← citeshttps://doi.org/10.7554/elife.96513.2openalex-snapshot
Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD)
inferred← citeshttps://doi.org/10.7554/elife.96513.3openalex-snapshot
Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD)
inferred← citeshttps://doi.org/10.7554/elife.96513.4openalex-snapshot
Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD)
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.